ArticleCancer discovery2022

EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.

Qibiao Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.